MIRM Q4 2021 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

MIRMMirum Pharmaceuticals, Inc.

$5B

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M

Gross Profit

$1M39.4% margin

Operating Income

-$46M-1452.4% margin

Net Income

$58M1833.8% margin

EPS (Diluted)

$1.88

QoQ Revenue Growth

-37.2%

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$52M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$295M

Total Liabilities

$174M

Stockholders' Equity

$120M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$0	—
Gross Profit	$1M	$0	—
Operating Income	-$46M	-$37M	-23.3%
Net Income	$58M	-$37M	+254.7%